alphaCD27 mAb

N/A

Report date: 2025/03/14 18:12:08

Base Information

Drug NamealphaCD27 mAb
Drug Alias NameCD27 costimulator (Kineta)fully human monoclonal alpha anti-CD27 agonist antibody program (Kineta)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionCD27 antigen agonists
TargetsCD27 antigen
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsOvarian Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKineta Inc
China Registration ClassN/A

Develop Information

Active CompaniesKineta Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic NeoplasmsOvarian Neoplasms +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A